NC-531 (Neurochem).

Name: NC-531 (Neurochem).
Creator: Hugo, Geerts
Keywords: 03 medical and health sciences, Structure-Activity Relationship, 0302 clinical medicine, Amyloid beta-Peptides, Clinical Trials, Phase II as Topic, Clinical Trials, Phase I as Topic, Alzheimer Disease, Polysaccharides, Animals, Humans

Hugo, Geerts

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2004

Data sources: Europe PubMed Central

NC-531 (Neurochem).

descriptionPublicationkeyboard_double_arrow_right Article 03 Jun 2004 English Journal:Current opinion in investigational drugs (London, England : 2000), volume 5 (issn: 1472-4472,

Copyright policy )

Authors: Hugo, Geerts;

pmid: 14983981

NC-531 (Neurochem).

- Summary
- Subjects
- Metrics

Abstract

NC-531 is a sulfated glycosaminoglycan mimetic that inhibits amyloid plaque formation, and is under development by Neurochem for the potential treatment of Alzheimer's disease. Phase I clinical trials of NC-531 were ongoing in November 1999, and by October 2002 phase II trials were underway.

Related Organizations

In Silico Biosciences (United States)
United States

Keywords

Structure-Activity Relationship, Amyloid beta-Peptides, Clinical Trials, Phase II as Topic, Clinical Trials, Phase I as Topic, Alzheimer Disease, Polysaccharides, Animals, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average